These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8855768

  • 21. Long-term prognosis of chronic hepatitis C after treatment with interferon alpha 2b and characterization of incomplete responders.
    Hakozaki Y, Shirahama T, Katou M, Nakagawa K, Oba K, Yoshii O, Matsumoto T, Kuwabara N, Mitamura K.
    Am J Gastroenterol; 1996 Oct; 91(10):2144-9. PubMed ID: 8855738
    [Abstract] [Full Text] [Related]

  • 22. [Interferon therapy in chronic viral hepatitis].
    Welland O.
    Nord Med; 1992 Oct; 107(3):72-3, 75. PubMed ID: 1549455
    [No Abstract] [Full Text] [Related]

  • 23. MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha.
    Bauduer F.
    Am J Hematol; 1996 Nov; 53(3):209. PubMed ID: 8895702
    [No Abstract] [Full Text] [Related]

  • 24. [Pathogenesis and alpha-2 interferon treatment of chronic hepatitis B].
    Pirotte J.
    Rev Med Liege; 1996 Aug; 51(8):514-21. PubMed ID: 8927872
    [No Abstract] [Full Text] [Related]

  • 25. Treatment with natural IFN of hepatitis C patients with or without antibodies to recombinant IFN.
    Milella M, Antonelli G, Santantonio T, Giannelli G, Currenti M, Monno L, Turriziani O, Pastore G, Dianzani F.
    Hepatogastroenterology; 1995 Jul; 42(3):201-4. PubMed ID: 7590565
    [Abstract] [Full Text] [Related]

  • 26. Randomized trial comparing three different regimens of interferon alfa 2a in chronic hepatitis C.
    Angelico M.
    Hepatology; 1996 Jun; 23(6):1709-10. PubMed ID: 8675201
    [No Abstract] [Full Text] [Related]

  • 27. Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha.
    Veerabagu MP, Finkelstein SD, Rabinovitz M.
    Dig Dis Sci; 1997 Jul; 42(7):1445-8. PubMed ID: 9246044
    [Abstract] [Full Text] [Related]

  • 28. Interferon therapy in hepatitis C.
    Zein NN, Rakela J.
    Semin Gastrointest Dis; 1995 Jan; 6(1):46-53. PubMed ID: 7894967
    [Abstract] [Full Text] [Related]

  • 29. Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C.
    Tada H, Saitoh S, Nakagawa Y, Hirana H, Morimoto M, Shima T, Shimamoto K, Okanoue T, Kashima K.
    J Gastroenterol; 1996 Aug; 31(4):582-4. PubMed ID: 8844482
    [Abstract] [Full Text] [Related]

  • 30. Combination treatment of advanced HCV associated liver disease with interferon and G-CSF.
    Van Thiel DH, Faruki H, Friedlander L, Fagiuoli S, Caraceni P, Molloy PJ, Kania RJ, Wright HI.
    Hepatogastroenterology; 1995 Aug; 42(6):907-12. PubMed ID: 8847044
    [Abstract] [Full Text] [Related]

  • 31. Chronic hepatitis C and markedly elevated serum alpha-fetoprotein: complete response to treatment with alpha-interferon.
    Weinberg DS, Malet PF.
    Am J Gastroenterol; 1994 Aug; 89(8):1253-4. PubMed ID: 7519819
    [No Abstract] [Full Text] [Related]

  • 32. [Esophageal candidiasis during interferon therapy for chronic viral hepatitis C].
    Prignet JM, Galzin M, Demarquay JF, Raynard B, Louvety S, Künkel D.
    Gastroenterol Clin Biol; 1994 Aug; 18(8-9):796-7. PubMed ID: 7875459
    [No Abstract] [Full Text] [Related]

  • 33. [Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C].
    Moulin V, Harzic M, Doll J, Dubeaux B, Ghnassia JC, Andrieu J.
    Pathol Biol (Paris); 1996 May; 44(5):468-72. PubMed ID: 8758497
    [Abstract] [Full Text] [Related]

  • 34. Interferon alpha 2a in patients of chronic hepatitis C.
    Zuberi SJ, Alam SE, Raza S.
    J Pak Med Assoc; 1994 Jul; 44(7):171-2. PubMed ID: 7933458
    [No Abstract] [Full Text] [Related]

  • 35. Antithyroid peroxidase antibody and development of silent thyroiditis during interferon-alpha 2a treatment of chronic hepatitis C.
    Wada M, Shimoyama T, Hamada A, Fukuchi M.
    Am J Gastroenterol; 1995 Aug; 90(8):1366-7. PubMed ID: 7639264
    [No Abstract] [Full Text] [Related]

  • 36. alpha-Interferon retreatment of patients with chronic hepatitis C.
    Rabinovitz M, Block G, Finkelstein SD.
    Am J Gastroenterol; 1996 Aug; 91(8):1523-6. PubMed ID: 8759654
    [Abstract] [Full Text] [Related]

  • 37. [Autoimmune thrombocytopenic purpura after treatment of chronic viral hepatitis C with interferon].
    Maïga MY, Oberti F, Foussard C, Calès P.
    Gastroenterol Clin Biol; 1995 Aug; 19(8-9):739-40. PubMed ID: 8522132
    [No Abstract] [Full Text] [Related]

  • 38. [Treatment with interferon alfa-2b in patients with chronic hepatitis caused by hepatitis C virus: predictive factors for the response, relapse and early development to cirrhosis after treatment].
    Pérez Roldán F, De Diego A, Casado M, Matilla A, Bañares R, García-Durán F, Salcedo M, Cos E, Clemente G.
    Rev Esp Enferm Dig; 1996 Sep; 88(9):609-15. PubMed ID: 8962775
    [Abstract] [Full Text] [Related]

  • 39. [Attempted suicide during treatment of chronic viral hepatitis C with interferon. Apropos of 2 cases].
    Bourat L, Larrey D, Michel H.
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1063. PubMed ID: 8729421
    [No Abstract] [Full Text] [Related]

  • 40. [Therapy of chronic hepatitis B, C and D with alpha-interferon].
    Niederau C.
    Fortschr Med; 1993 Feb 28; 111(6):35-7. PubMed ID: 8462911
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.